We are live on ! Find out more
COCH icon

Envoy Medical
COCH

85 hedge funds and large institutions have $325M invested in Envoy Medical in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 5

6% more funds holding

Funds holding: 80 → 85 (+5)

1.08% more ownership

Funds ownership: 77.02% → 78.1% (+1.1%)

2% more capital invested

Capital invested by funds: $319M → $325M (+$5.55M)

23% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 13

Holders
85
Holders Change
+5
Holders Change %
+6.25%
% of All Funds
1.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
10
Reduced
13
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HSBC Holdings
HSBC Holdings
United Kingdom
+$10.2M
2
GCL
Glazer Capital LLC
New York
+$8.08M
3
CF
Cantor Fitzgerald
New York
+$2.85M
4
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
+$973K
5
TCM
Tegean Capital Management
New York
+$681K

Top Sellers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$9.65M
2
Millennium Management
Millennium Management
New York
-$3.3M
3
MP
Mangrove Partners
Connecticut
-$1.88M
4
Goldman Sachs
Goldman Sachs
New York
-$1.51M
5
PC
Periscope Capital
Ontario, Canada
-$1.46M

COCH Hedge Fund Activity: Q1 2022 in Review

85 of the 6,361 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q1 2022, worth a combined $325M — up 1.7% from $319M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new COCH positions and 5 closed out — a net gain of 5 holders — while 10 added to existing stakes and 13 trimmed.

The largest buyer was HSBC Holdings, opening a new position worth an estimated $10.2M. The largest seller was D.E. Shaw & Co, cutting an estimated $9.65M.

  • 85 institutional investors held Envoy Medical (COCH) as of Q1 2022, up from 80 in Q4 2021.
  • Funds reported $325M of Envoy Medical stock for Q1 2022, up 1.7% quarter-over-quarter.
  • 10 funds opened new Envoy Medical positions in Q1 2022 and 5 closed out, a net change of +5 holders.
  • The largest Envoy Medical buyer in Q1 2022 was HSBC Holdings, an estimated $10.2M added.
  • The largest Envoy Medical seller in Q1 2022 was D.E. Shaw & Co, an estimated $9.65M sold.

Based on aggregated 13F filings for Q1 2022.